| 000 | 01247 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513231815.0 | ||
| 264 | 0 | _c20010308 | |
| 008 | 200103s 0 0 fre d | ||
| 022 | _a0040-5957 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMasmoudi, K | |
| 245 | 0 | 0 |
_a[Dementia and extrapyramidal problems caused by long-term valproic acid]. _h[electronic resource] |
| 260 |
_bTherapie _c |
||
| 300 |
_a629-34 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnticonvulsants _xadverse effects |
| 650 | 0 | 4 |
_aBasal Ganglia _xmetabolism |
| 650 | 0 | 4 |
_aBasal Ganglia Diseases _xchemically induced |
| 650 | 0 | 4 |
_aDementia _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGABA Agonists _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aParkinson Disease, Secondary _xchemically induced |
| 650 | 0 | 4 |
_aValproic Acid _xadverse effects |
| 650 | 0 | 4 |
_agamma-Aminobutyric Acid _xmetabolism |
| 700 | 1 | _aGras-Champel, V | |
| 700 | 1 | _aBonnet, I | |
| 700 | 1 | _aPannier, M | |
| 700 | 1 | _aMasson, H | |
| 700 | 1 | _aRosa, A | |
| 700 | 1 | _aAndréjak, M | |
| 773 | 0 |
_tTherapie _gvol. 55 _gno. 5 _gp. 629-34 |
|
| 999 |
_c11140031 _d11140031 |
||